BofA Securities Downgrades Vir Biotechnology (VIR) to Neutral, 'Near-term data unlikely to lift sentiment'
Tweet Send to a Friend
(Updated - September 8, 2023 7:45 AM EDT)
BofA Securities analyst Geoff Meacham downgraded Vir Biotechnology (NASDAQ: VIR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Geoff Meacham downgraded Vir Biotechnology (NASDAQ: VIR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
